2341-4545

2341-4545

S2341-45452021000100013

10.1159/000507206

Portugal

Portugal

Portugal

Portugal

Portugal

Canada

Portugal

27 02 2021

27 02 2021

28 1 13 25

1

2012 16 8 8

1478-86

2

2016 22 28 28

6456-68

3

2016 103 4 4

434-42

4

2018 97 39 39

5

2016 19 9 9

1593-602

6

2018 9 1 1

24-34

7

2018 24 3 3

278-84

8

2017 39 39

45-51

9

2018 13 5 5

10

2018 9 2 2

326-34

11

2015 157 6 6

1088-98

12

2009 15 22 22

6973-9

13

2017 8 2 2

317-26

14

2004 240 2 2

205-13

15

2008 33 5 5

997-1006

16

2013 31 12 12

1539-47

17

2003 11 12 12

1488-94

18

2008 9 7 7

629-35

19

2015 6 4 4

489-97

20

2015 22 13 13

4445-52

21

2013 109 2 2

302-12

22

2016 35 5 5

1103-9

23

2018 25 5 5

1160-6

24

2014 1985

1071-7

25

2018 68

124-35

26

2018 18 1 1

2-11

27

Canadian Cancer Trials Group and the Unicancer-GI-PRODIGE Group 2018 379 25 25

2395-406

28

2017 15 8 8

1028-61

29

2016 51 2 2

159-78

30

2018 9 2 2

295-305

31

2014 2015 111 111

771-5